A study conducted by researchers from Wageningen University in the Netherlands says that a chewing gum laced in cannabis can cure irritable bowel syndrome, reducing painful stomach cramps, control bloating and normalise stool.
Speaking about the study, the researchers said, We are excited to see that Axim Biotechnologies Inc (AXIM) has reached another milestone in its clinical development program. This is the first advancement in cannabinoid research for treatment of IBS in medical history and gives a clear example of how far ahead AXIM is in its clinical development programs. This is the first of its kind to test a relationship between CBD and IBS. From next month, the trial will begin, testing a cannabis-infused chewing gum made by US firm Medical Marijuana Inc. They will give trial to 40 participants, aged between 18 and 65, alongside matching placebo gums. Preliminary research suggests the product could reduce painful stomach cramps, control bloating, and normalize stool. The cost to society in terms of direct medical expenses and indirect costs associated with loss of productivity and work absenteeism tied to IBS is considerable.